ArticleHematology reports2025

Multi-Organ Adverse Reaction to Two Hypomethylating Agents: A Challenge in High-Risk Myelodysplastic Syndrome Treatment.

Sofia Brites Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.